Item 1.01. Entry into a Material Definitive Agreement.
Public Offering
On
The Company granted the Underwriters a 45-day over-allotment option to purchase
up to 2,264,150 additional shares of Common Stock. The Company also paid the
Underwriters an underwriting discount equal to 7.0% of the gross proceeds of the
Offering and a non-accountable expense fee equal to 1.5% of the gross proceeds
of the Offering. In addition, the Company agreed to issue to the representative
warrants (the "Representative's Warrants") to purchase a number of shares equal
to 3.0% of the aggregate number of shares (including shares underlying the
Pre-funded Warrants) sold under in the Offering, or warrants to purchase up to
an aggregate of 520,754 shares, assuming the Underwriters exercise their
over-allotment option in full. The Representative's Warrants have an exercise
price equal to 125% of the public offering price, or
The Company and its directors and executive officers also agreed that, for a
period of one (1) year and ninety (90) days, respectively, after the date of the
offering, subject to certain limited exceptions, not to directly or indirectly,
without the prior written consent of the Underwriters, (a) offer, sell, or
otherwise transfer or dispose of, directly or indirectly, any shares of capital
stock of the Company or any securities convertible into or exercisable or
exchangeable for shares of capital stock of the Company; or (b) file or caused
to be filed any registration statement with the
The Pre-funded Warrants were offered and sold to purchasers whose purchase of
Common Stock in the Offering would otherwise result in the purchaser, together
with its affiliates and certain related parties, beneficially owning more than
4.99% (or, at the election of the purchaser, 9.99%) of the Company's outstanding
Common Stock immediately following the consummation of the Offering in lieu of
Common Stock that would otherwise result in the purchaser's beneficial ownership
exceeding 4.99% of the Company's outstanding Common Stock (or, at the election
of the purchaser, 9.99%). Each Pre-funded Warrant is exercisable for one share
of Common Stock at an exercise price of
The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions. The Underwriting Agreement provides for indemnification by the Underwriters of the Company, its directors and certain of its executive officers, and by the Company of the Underwriters, for certain liabilities, including liabilities arising under the Securities Act of 1933, as amended, and affords certain rights of contribution with respect thereto.
The net proceeds to the Company from the Offering was approximately
A registration statement on Form S-1 relating to the Offering (File No.
333-258139) was declared effective by the
Pre- funded Warrants
The Pre-funded Warrants were issued in registered form under a warrant agent
agreement (the "Warrant Agent Agreement") between the Company and
The Pre-Funded Warrant entitles the holder thereof to purchase one share of
Common Stock at an exercise price of
Pre-funded Warrant holders, subject to limited exceptions, cannot exercise their warrants to the extent that, after giving effect to such exercise, the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, at the election of the purchaser, 9.99%; subject to increase at the option of the holder to 9.99% upon 61 days' prior written notice) of the Company's Common Stock outstanding immediately after giving effect to the exercise.
The foregoing summary of the terms of the Underwriting Agreement and the Warrant
Agent Agreement (including the Pre-funded Warrants and the Representative's
Warrants) are subject to, and qualified in their entirety by reference to,
copies of the Underwriting Agreement, the Warrant Agent Agreement (including the
Pre-funded Warrants) and the Representative's Warrants that are filed as
exhibits to this Current Report on Form 8-K and are incorporated herein by
reference. The representations, warranties and covenants contained in the
Underwriting Agreement were made only for purposes of such agreement and, as of
specific dates, were solely for the benefit of the parties to the Underwriting
Agreement, and may be subject to limitations agreed upon by the contracting
parties. Accordingly, the Underwriting Agreement is incorporated herein by
reference only to provide investors with information regarding the terms of the
Underwriting Agreement, and not to provide investors with any other factual
information regarding the Company or its business, and should be read in
conjunction with the disclosures in the Company's periodic reports and other
filings with the
Item 8.01. Other Events.
On
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit Description 1.1 Underwriting Agreement, dated as ofJuly 27, 2021 , by and betweenAlset EHome International Inc. andAegis Capital Corp. , as representative of the underwriters named therein 4.1 Warrant Agent Agreement (including the terms of the Pre-funded Warrant) 4.2 Representative's Warrant 99.1 Press Release, datedJuly 27, 2021 99.2 Press Release, datedJuly 30, 2021
© Edgar Online, source